Paysign delivers strong revenue guide on growing patient affordability business
Paysign (PAYS) delivered above-consensus guidance for both Q1 2025 and for the full year, as the company expects its patient ...
Paysign projects 100% growth in pharma patient affordability revenue for 2025
Gain insights into Paysign, Inc.'s Q4 2024 performance, driven by 212% growth in patient affordability revenue.
Las Vegas Sun14h
Paysign, Inc. Announces Acquisition of Gamma Innovation’s Assets, Appoints Michael Ngo as Chief Innovation Officer
Paysign, Inc. (NASDAQ: PAYS), a leading provider of patient affordability solutions, financial technology products, and integrated payment processing services, today announced that it has acquired the ...
Paysign, Inc. (PAYS): A Bull Case Theory
We came across a bullish thesis on Paysign, Inc. (PAYS) on Substack by Taylor Nichols. In this article, we will summarize the ...